In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
The competition regulator’s complaint names CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum, which administer about 80 per cent of all prescriptions in the US and ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
Regulator claims companies rigged pharmaceutical supply chain competition in their favor, forced patients to pay more for ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though prescribed for the past 100 years, only three companies supply insulin in the ...
(Reuters) - The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback